Medprin Regenerative Medical Technologies (301033.SZ): Absorbable regenerative oxidized cellulose hemostatic particles have entered the clinical trial stage.
Map Medical (301033.SZ) announcement, the company's research and development project "absorbable regenerated cellulose hemostatic particles" ...
Medprin Regenerative Medical Technologies (301033.SZ) announces that the company's research and development project "Absorbable Regenerated Oxidized Cellulose Hemostatic Particles" has officially entered the clinical trial phase recently. In surgical procedures, when conventional methods of hemostasis such as ligation are not feasible or ineffective, this product can be used as an adjunct hemostatic product to control oozing from capillaries, veins, and small arteries.
Related Articles
New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?
Guosen: The final mindset of asset trend convergence.
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?
Guosen: The final mindset of asset trend convergence.
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
